Skip to main content
SpringerLink
Log in

Prognostic significance in malignant melanoma of nuclear DNA content measured by a microfluorimetric method

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

The nuclear DNA content of 47 primary malignant melanomas was measured by 4′,6-diamidino-2-phenylindole-DNA (DAPI-DNA) microfluorimetry, and the DNA index, a quantitative measure of nuclear DNA content, was calculated. The DNA index and other clinical and pathological variables were examined and compared with patient survival using univariate and multivariate analyses. The Kaplan-Meier life table method revealed that the DNA index and metastases to regional lymph nodes significantly correlated with patient survival. A Cox proportional hazards multivariate analysis demonstrated that the DNA index, which was not significantly correlated with other variables, was the most reliable and independent factor for predicting patient survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Büchner TH, Hiddemann B, Wörmann B, Kleinemeier B, Schumann J, Göhde W, Ritter J, Müller KM, Bassewitz DB, Roessner A, Grundmann E (1985) Differential pattern of DNA-aneuploidy in human malignancies. Pathol Res Pract 179: 310–317

    PubMed  Google Scholar 

  2. Barlogie B, Raber MN, Schumann J, Johnson TS, Drewinko B, Swartzendruber DE, Göhde W, Andreeff M, Freireich EJ (1983) Flow cytometry in clinical cancer research. Cancer Res 43: 3982–3997

    PubMed  Google Scholar 

  3. Friedlander ML, Hedley DW, Taylor IW (1984) Clinical and biological significance of aneuploidy in human tumours. J Clin Pathol 37: 961–974

    PubMed  Google Scholar 

  4. Ohnishi K, Ishikawa H (1991) Flow cytometric DNA analysis of primary cutaneous malignant melanoma. Acta Derm Venereol (Stockh) 71: 525–540

    Google Scholar 

  5. Van Oven MW, Oosterhuis JW, Koops HS, Dam-Meiring A (1992) Significance of aneuploidy in melanoma of the extremity. Cancer 70: 109–113

    PubMed  Google Scholar 

  6. Otsuka F, Shima A, Ishibashi Y (1989) Porokeratosis as a premalignant condition of the skin: cytologic demonstration of abnormal DNA ploidy in cells of the epidermis. Cancer 63: 891–896

    PubMed  Google Scholar 

  7. Lindholm C, Hofer P-Å, Jonsson H (1990) Single cell DNA cytophotometry in clinical stage I malignant melanoma. Acta Oncol 29: 147–150

    PubMed  Google Scholar 

  8. Chi H-I, Ishibashi Y, Shima A, Mihara I, Otsuka F (1990) Use of DAPI cytofluorometric analysis of cellular DNA content to differentiate Spitz nevus from malignant melanoma. J Invest Dermatol 95: 154–157

    PubMed  Google Scholar 

  9. Otsuka F, Chi H-I, Umebayashi Y (1993) Successful differentiation of Spitz naevus from malignant melanoma by microfluorometric analysis of cellular DNA content. Clin Exp Dermatol 18: 421–424

    PubMed  Google Scholar 

  10. Chi H-I, Uyeda Y, Umebayashi Y, Otsuka F (1993) Epithelioid cell melanomas have greater DNA ploidy abnormalities than spindle cell melanomas: cytological evidence for a higher malignant potential of the former. Arch Dermatol Res 285: 410–414

    PubMed  Google Scholar 

  11. Clark WH, From L, Bernardio EA, Mihm MC Jr (1969) The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 29: 705–715

    PubMed  Google Scholar 

  12. Karlsson M, Boeryd B, Carstensen J, Kågedal B, Bratel AT, Wingren S (1993) DNA ploidy and S-phase in primary malignant melanoma as prognostic factors for stage III disease. Br J Cancer 67: 134–138

    PubMed  Google Scholar 

  13. Muhonen T, Pyrhønen S, Laasonen A, Asko-Seljavaara S, Franssila K (1991) DNA aneuploidy and low S-phase fraction as favourable prognostic signs in metastatic melanoma. Br J Cancer 64: 749–752

    PubMed  Google Scholar 

  14. Muhonen T, Pyrhønen S, Laasonen A, Wasenius V-M, Asko-Seljavaara S, Franssila K, Kangas L (1992) Tumor growth rate and DNA flow cytometry parameters as prognostic factors in metastatic melanoma. Br J Cancer 66: 528–532

    PubMed  Google Scholar 

  15. Balch CM, Soong S-J, Murad TM-Ingalls AL, Maddox WA (1979) A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery 86: 343–351

    PubMed  Google Scholar 

  16. Day CL, Sober AJ, Kopf AW, Lew RA, Mihm MC, Hennessey P, Golomb FM, Harris MN, Gumport SL, Raker JW, Malt RA, Cosimi AB, Wood WC, Roses DF, Gorstein F, Postel A, Grier WRN, Mintzis MN, Fitzpatrick TB (1981) A prognostic model for clinical stage I melanoma of the upper extremity: the importance of anatomic subsites in predicting recurrent disease. Ann Surg 193: 436–440

    PubMed  Google Scholar 

  17. Veronesi U, Cascinelli N, Morabito A, Bufalino R, Van der Esch EP, Preda F, Vaglini M, Rovini D, Orefice S (1980) Prognosis of stage I melanoma of the skin. Int J Cancer 26: 733–739

    PubMed  Google Scholar 

  18. Rogers GS, Kopf AW, Rigel DS, Friedman RJ, Levine JL, Levenstein M, Bart RS, Mintzis MM (1983) Effect of anatomical location on prognosis in patients with clinical stage I melanoma. Arch Dermatol 119: 644–649

    PubMed  Google Scholar 

  19. Kheir SM, Bines SD, Vonroenn JH, Soong S-J, Urist MM, Coon JS (1988) Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma. Ann Surg 207: 455–461

    PubMed  Google Scholar 

  20. Silver HB, Karim KA, Riche JL, Jong GD, Spinelli J, Worth A, Mclean DI, Gallagher R (1989) Nuclear DNA, serum sialic acid and measured depth in malignant melanoma for predicting disease recurrence and survival. Int J Cancer 44: 31–34

    PubMed  Google Scholar 

  21. Gattuso P, Reddy Y, Solans E, Kathuria S, Aranha GV, Jacob HK, Walloch J (1990) Is DNA ploidy of prognostic significance in stage I cutaneous melanoma? Surgery 108: 702–709

    PubMed  Google Scholar 

  22. Hansson J, Tribukait B, Lewensohn R, Ringborg Ulrik (1982) Flow cytometric DNA analyses of metastases of human malignant melanomas. Anal Quant Cytol 67: 99–104

    Google Scholar 

  23. Søndergaar K, Larsen JK, Møller U, Christensen IJ, Hou-Jensen K (1983) DNA-ploidy-characteristics of human malignant melanoma analyzed by flow cytometry and compared with histology and clinical course. Virchows Arch [B] Cell Pathol 42: 43–52

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Institute of Clinical Medicine, University of Tsukuba, 1-1-1 Ten-nodai, Tsukuba, 305, Ibaraki, Japan

    Yoshihiro Umebayashi & Fujio Otsuka

Authors
  1. Yoshihiro Umebayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fujio Otsuka
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Umebayashi, Y., Otsuka, F. Prognostic significance in malignant melanoma of nuclear DNA content measured by a microfluorimetric method. Arch Dermatol Res 287, 718–722 (1995). https://doi.org/10.1007/BF01105795

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01105795

Key words

Search

Navigation